Filtered By:
Condition: Sleep Disorders
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 58948 results found since Jan 2013.
Medical and surgical care during the American Civil War, 1861-1865.
Abstract
This review describes medical and surgical care during the American Civil War. This era is often referred to in a negative way as the Middle Ages of medicine in the United States. Many misconceptions exist regarding the quality of care during the war. It is commonly believed that surgery was often done without anesthesia, that many unnecessary amputations were done, and that care was not state of the art for the times. None of these assertions is true. Physicians were practicing in an era before the germ theory of disease was established, before sterile technique and antisepsis were known, with very few e...
Source: Baylor University Medical Center Proceedings - March 31, 2016 Category: Universities & Medical Training Authors: Reilly RF Tags: Proc (Bayl Univ Med Cent) Source Type: research
Inspire Medical Systems raises $13m for sleep apnea device
Inspire Medical Systems has raised $12.5 million in a new round of equity financing, according to an SEC filing posted today.
Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep.
The company won FDA approval for the device in May 2014. The company was spun out of Medtronic in 2007, using concepts for devices from trials when began in 1998.
Money in the round came from 22 anonymous sources, according to an SEC filing, with the company looking to bring in another $25 million before closing the round.
Inspire Medical Systems has n...
Source: Mass Device - November 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Respiratory Inspire Medical Systems Inc. Source Type: news
Medical Decisions of Pediatric Residents Turn Riskier after a 24-Hour Call with No Sleep
Conclusions. This study suggests that residents napping less than an hour during a night shift are prone to riskier clinical decisions. Hence, enabling residents to nap at least 1 hour during shifts is recommended.
Source: Medical Decision Making - November 28, 2016 Category: Health Management Authors: Aran, A., Wasserteil, N., Gross, I., Mendlovic, J., Pollak, Y. Tags: Original Articles Source Type: research
Fears from a medical student part II: Prepping the patient
Veins replete with burning medicine, his eyes shiver shut. Is it quite the same to call this sleep? He's surrounded by masks, whispering and weaving, cleansing his arms, piercing taut skin. A catheter slithers into the anatomical pouch as the soft roar of razor denudes his abdomen. The tape recruits every last hair. Paintbrush to belly button, spreading orange chlorhexidine across the impact line. The man we know is gone, and in his place— nine square inches of skin framed by tape and sheets. The overhead lights turn on. "Time out!" All look up for a moment and nod, to show no wrong. To acknowledge the tissue that wa...
Source: Medical Humanities - February 21, 2017 Category: Global & Universal Authors: Prabhu, A. V., Kashkoush, A. Tags: Poetry and prose Source Type: research
Comorbidity of Chronic Gastro-Esophageal Reflux (GERD) with Sleep and Medical Disorders in a Longitudinal Survey of he American General Population (P3.057)
Conclusions:Nocturnal awakenings are highly prevalent among individuals affected by GERD. GERD chronicity is strongly predicted by insomnia disorder, sleep dissatisfaction, difficulty initiating sleep, major depressive disorder and various medical disorders. Physicians must be aware of these predisposing conditions and factors of chronicity involving Sleep Disorders.Study Supported by: Educational grant from Takeda Pharmaceuticals.Disclosure: Dr. Ohayon has received personal compensation for activities with Sanofi-Aventis Pharmaceuticals, Inc. as a speaker. Dr. Ohayon has received research support from Jazz Pharmaceuticals...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Ohayon, M., Milesi, C., van Dijk, M. Tags: Sleep Disruption and Medical Co-Morbidities Source Type: research
LivaNova puts $225m on the table for ImThera Medical
LivaNova (NSDQ:LIVN) said today that it agreed to a deal for ImThera Medical and its implantable sleep apnea treatment worth $225 million.
San Diego-based ImThera’s flagship product is the Aura6000, an implanted hypoglossal nerve stimulator that won FDA investigational device exemption in November 2014 for a pivotal trial. The device uses a pair of implanted components, one near the collarbone and one in the upper neck, to stimulate tongue muscles to help control upper airway flow and reduce or eliminate sleep apnea.
LivaNova, already in investor in ImThera, said it would pay $78 million up front to acquire the r...
Source: Mass Device - December 5, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Neuromodulation/Neurostimulation Respiratory ImThera Medical Inc. LivaNova Source Type: news
Medical Issues in Playing the Oboe: A Literature Review.
Authors: Banzhoff S, Del Mar Ropero M, Menzel G, Salmen T, Gross M, Caffier PP
Abstract
Playing a musical instrument can affect physical and mental health. A literature review was conducted to determine the prevalence of health problems among oboists, which medical conditions can be caused or exacerbated by playing, whether oboe playing can be a protective factor, and whether recommendations are possible as to who should or should not play the oboe. Searches in 7 databases (Medline, Embase, Cochrane Library, Web of Science, SocIndex, PsyIndex, Psychinfo) yielded a total of 950 studies; after exclusion of duplicates...
Source: Medical Problems of Performing Artists - December 13, 2017 Category: Sports Medicine Tags: Med Probl Perform Art Source Type: research
Inspire Medical plans $86m IPO
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007 and creates devices for treating obstructive sleep apnea, said last Friday it is looking to launch an initial public offering that could bring in as much as $86.3 million for the company.
Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep.
The Minneapolis-based company said it plans to offer shares under the NYSE ticker symbol “INSP”.
Last year, the company reported sales of $28.6 million and approximately $22.6 in gross profit, with $17.5 ...
Source: Mass Device - April 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Respiratory Inspire Medical Systems Inc. Source Type: news
Don ' t Use Medical Marijuana for Sleep Apnea, AASM Warns Don ' t Use Medical Marijuana for Sleep Apnea, AASM Warns
Medical cannabis and synthetic marijuana extracts should not be used to treat obstructive sleep apnea, the American Academy of Sleep Medicine says in a new position statement.Medscape Medical News
Source: Medscape Medical News Headlines - April 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Medtronic spinout Inspire Medical sets range for $75m IPO
Inspire Medical Systems this week set the range for a proposed initial public offering that would fetch $75 million at the midpoint.
Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company said it plans to issue 5 million shares at $14 to $16 apiece, setting its market capitalization at roughly $305 million.
Inspire, which posted net losses of -$17.5 million on sales of $28.6 million last year, plans to list on the New York Stock Exchange under the INSP symbol. The flotation is slated to price next week.
The company developed a p...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Inspire Medical Systems Inc. Medtronic Source Type: news
Inspire Medical prices up-sized $108m IPO
Inspire Medical Systems yesterday up-sized its initial public offering to $108 million, or some $124 million if the underwriters option is exercised in full.
Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company had said it planned to issue 5 million shares at $14 to $16 apiece, which would have fetched $75 million at the midpoint.
But in a regulatory filing yesterday, Inspire said it sold 6.75 million shares at $16 apiece and put an underwriters option on the table that’s worth another $16.2 million.
Inspire, which post...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Neuromodulation/Neurostimulation Respiratory Wall Street Beat Inspire Medical Systems Inc. Source Type: news
Inspire Medical offers another 1.5 million shares following April IPO
Inspire Medical Systems (NYSE: INSP) is offering 1.5 million shares of common stock for sale to the public, and its stockholders are selling 1 million additional shares of the stock, according to a regulatory filing. The company hopes to make $66.8 million on the sale.
Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company had said it planned to issue 5 million shares at $14 to $16 apiece in its IPO in April 2018, but in May upped the offering to a least $108 million.
Inspire posted a net loss of $17.1 million for the nine mo...
Source: Mass Device - December 4, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Respiratory Wall Street Beat Inspire Medical Systems Inc. Source Type: news
CES 2019: Medical technologies you need to know
Mobile health devices and wearables are increasingly playing a prominent role at the annual CES show in Las Vegas, with 505 digital health and 620 wearables exhibitors at this year’s show.
Health and medical devices touted at CES 2019 – Jan. 8–11 – were meant to improve everything from posture to sleep analysis. Time will tell which companies and technologies pan out.
Here are nine companies exhibiting digital health products at this year’s show.
Next >>
The post CES 2019: Medical technologies you need to know appeared first on MassDevice.
Source: Mass Device - January 7, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Diagnostics Hospital Care Imaging mHealth (Mobile Health) Patient Monitoring Research & Development Software / IT Aris MD Aulisa Medical CES Equadex Medical Wearable Solutions Pulsewear TestCard Vayyar Wefight Xandar Kardia Source Type: news
Inspire Medical Systems lands insurer reimbursement win
Inspire Medical Systems said yesterday that it won a positive coverage policy for its Inspire therapy, intended to treat obstructive sleep apnea, from insurer Blue Cross of Idaho.
The Minneapolis-based company’s Inspire system is a closed-loop, pacemaker-like system designed to stimulate nerves to keep airways open during sleep to treat obstructive sleep apnea.
The coverage policy issuance comes shortly after the Blue Cross Blue Shield Association’s Evidence Street issued a positive assessment of Inspire therapy to its members.
The new reimbursement win will make the therapy available to Blue Cross of Idaho’s...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Inspire Medical Systems Inc. Source Type: news
Inspire Medical wins more Blue Cross Blue Shield coverage
Five more Blue Cross Blue Shield health plans have extended coverage to Inspire Medical Systems’ (NYSE:INSP) sleep apnea therapy, the company said today.
These plans and the effective dates of their coverage are:
Independence Blue Cross, in Pennsylvania, March 4, 2019;
Blue Cross Blue Shield of Louisiana, Feb. 20, 2019;
Wellmark, in Iowa and South Dakota, Jan. 1, 2019;
HealthNow New York, April 1, 2019
BCBS of Kansas City, March 1, 2019.
Together, these plans provide coverage for approximately 8.5 million members. Thirteen BCBS plans covering about 25 million members have issued coverage policies for the compan...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Neuromodulation/Neurostimulation News Well Wall Street Beat Blue Cross Blue Shield Inspire Medical Systems Inc. Source Type: news
